Kyowa In The News
2012
Sustamine™ absorbs from gut to blood better than glutamine alone, study shows
May 7, 2012
NEW YORK CITY - Blood levels of L-Glutamine—the most abundant amino acid in human muscles and blood—were higher in healthy human participants after they ingested Sustamine™
Sustamine Maintains Performance Levels For Collegiate Basketball Players, Study Shows
March 20, 2012
NEW YORK CITY - Collegiate female basketball players maintained better skill performance and visual reaction time using water mixed with Sustamine.
KYOWA HAKKO USA announces program to highlight quality, scientifically backed nature of its ingredients
February 1, 2012
NEW YORK CITY - All amino acids are not created equal, and that's especially true of ingredients manufactured by Kyowa Hakko Bio Co. Ltd.
2011
New Cardiovascular Disease Research Shows Pantesin® Significantly Lowers LDL Cholesterol Levels
October 26, 2011
A clinical study published in Nutrition Research shows individuals supplementing their diets with Pantesin®, a highly absorbable and biologically active form of Vitamin B5, significantly lowered their LDL cholesterol levels.
John Rumberger, M.D., Ph.D, To Present New Cardiovascular Disease Research At SupplySide West
September 26, 2011
SupplySide West attendees interested in learning about the latest in heart health research are invited to attend an education session led by John Rumberger, M.D., Ph.D., FACC, Director of Cardiac Imaging at the Princeton Longevity Center on Thursday, October 13 from 10 a.m. - 10:50 a.m. in the Lido room 3005.
Cognizin® Citicoline's Role in Brain Function Highlighted in Natural Medicine Journal Podcast
July 14, 2011
In a sponsored podcast interview with peer-reviewed Natural Medicine Journal, University of Utah Brain Institute researcher Deborah Yurgelun-Todd, Ph.D., discusses the cognitive health benefits of Cognizin® Citicoline, as well as describes her most recent research, including new data presented at the New Clinical Drug Evaluation Unit (NCDEU) Annual Meeting, organized by the American Society of Clinical Psychopharmacology and the National Institutes of Health.
Kyowa Hakko Bio Announces Global Price Increase
July 1, 2011
Kyowa Hakko Bio Co., Ltd, confirmed today it is implementing a global 10 percent price increase on all new business for all company products, due to rising corn and fuel prices worldwide. That includes products sold by Kyowa Hakko USA.
Multitasking Much? Find Your Focus With This Nutrient, Says Study
June 14, 2011
Distractions are an inevitable result of a wired, work-anywhere world, and research has shown that tuning out competing stimuli to focus on a task helps with tackling our increasingly long to-do lists. Fortunately, focus and attention are two areas that can be improved through nutrition, according to new research being presented by members of the University of Utah Brain Institute this week.
Kyowa Hakko USA Appoints Mary Murphy Southeastern Region Sales Manager
April 18, 2011
Kyowa Hakko USA today announced that Mary Murphy has been named Southeastern sales manager. In this position, Murphy will be charged with supporting and expanding Kyowa Hakko USA's strong position with customers in the Southeast, as well as growing the company's customer base within the region.
Cognizin® Citicoline Receives Frost & Sullivan Award for Product Differentiation Excellence in Cognitive Health Ingredients
March 22, 2011
Cognizin® Citicoline, a brain health ingredient from Kyowa Hakko USA, has received the 2010 Frost & Sullivan "Product Differentiation Excellence" award in the cognitive health ingredients category for its brain-supporting properties proven through relevant science and increasing market popularity.
Think You Know Everything About Cognizin®? Think Again. New Research to be Presented During Education Session at SupplyExpo.
February 28, 2011
Deborah Yurgelun-Todd, Ph.D., Director of the Cognitive Neuroimaging Laboratory at The Brain Institute at The University of Utah, will present new scientific data on Kyowa Hakko's branded brain health ingredient Cognizin(R) in an education session entitled "Attention, Memory & Recall: Cognizin's Role in Brain Function" at SupplyExpo on Saturday, March 12 from 3 - 4 p.m. in room 207C. Dr. Yurgelun-Todd will highlight results of a six-week study conducted at McLean Hospital, a Harvard Medical School affiliate located in Belmont, Mass., designed to measure and visualize the functional effects of Cognizin on various facets of brain function.
Dean P. Jones, Ph. D. of Emory University Publishes his Scientific Review of Glutathione's Function in Health and Disease in Natural Medicine Journal
February 8, 2011
Glutathione, a naturally occurring chemical found in every cell of the human body, and its role in health and disease was the subject of a comprehensive scientific review published in the February 2011 issue of Natural Medicine Journal (www.naturalmedicinejournal.com). Dean P. Jones, Ph.D., Professor, Division of Pulmonary Medicine at Emory University compiled "The Health Dividend of Glutathione," which includes: an overview of glutathione and where it is found in the body; a review of how glutathione is maintained in tissues and body fluids; discussion of glutathione deficiency, the gap that exists between available glutathione and the amount needed for optimal health; and a summary of clinically supported strategies for improving the body's glutathione levels.
New Research Confirms Cognizin® Citicoline Effective for Improving Attention at a Dose of 250 mg
May 16, 2011
New York, NY – Research conducted at the University of Utah Brain Institute revealed that individuals receiving Cognizin(R) Citicoline at a dose of 250 mg showed improved attention and a better ability to produce correct responses in performance testing. Participants who were administered either the 250 mg or the 500 mg dose of Cognizin produced nearly identical results when compared to the placebo group, confirming that 250 mg is an efficacious dose for producing improvements in attention.
Archived News by Year:
Subscribe:
Sign up for our mailing list to receive our newsletter and news alerts.
